The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vincristine     Quarter: 2016Q3

Total Drug/Injury Combinations: 1,179     Number of Pages: 59

DRUGNAME PT EventCount
VINCRISTINE Ewing's sarcoma 3 view events
VINCRISTINE Fall 3 view events
VINCRISTINE Febrile infection 3 view events
VINCRISTINE Follicle centre lymphoma, follicular grade I, II, III recurrent 3 view events
vincristine Fusarium infection 3 view events
VINCRISTINE Gastrointestinal haemorrhage 3 view events
VINCRISTINE Gastrointestinal perforation 3 view events
Vincristine Gastrointestinal stoma output abnormal 3 view events
Vincristine Gastrointestinal toxicity 3 view events
vincristine Haemarthrosis 3 view events
VINCRISTINE Hepatic function abnormal 3 view events
vincristine Hyperglycaemia 3 view events
Vincristine Hypertension 3 view events
Vincristine Hypotonia 3 view events
VINCRISTINE Hypoxia 3 view events
VINCRISTINE Ileus 3 view events
VINCRISTINE Kidney infection 3 view events
Vincristine Lymphopenia 3 view events
vincristine Mental status changes 3 view events
vincristine Metapneumovirus infection 3 view events

Total Drug/Injury Combinations: 1,179     Number of Pages: 59

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)